viewIdeanomics Inc

Ideanomics says MEG division delivered 439 vehicles in December

The company said 356 were for the taxi/ride-hailing business, with 83 for the rental-car business

Ideanomics Inc - Ideanomics Inc says its Mobile Energy Global (MEG) division delivered 439 vehicles for December
For the 4Q, the Mobile Energy Global division delivered one charging systems and 13 CATL battery systems

Ideanomics Inc (NASDAQ:IDEX) (FRA:0V5) announced Friday, its Mobile Energy Global (MEG) division delivered 439 vehicles in December. 

The company said 356 were for the taxi/ride-hailing business and the remaining 83 for the rental-car business. 

All units, invoiced during the period from July through December 2020, were delivered, the company added in a statement. 

READ: Ideanomics announces sponsorship in the North American Council for Freight Efficiency

For the fourth quarter, Ideanomics said MEG delivered one charging system and 13 CATL battery systems -- which are part of an ongoing order for converting diesel-powered buses to battery electric vehicles (BEVs). 

The company noted that the 4Q results do not include any units from the recently announced deal with BYD and Didi for 2,000 units of their D1 ride-hailing vehicle.

Ideanomics is a global company focused on the convergence of financial services and industries experiencing technological disruption. 

The company is headquartered in New York City with offices in Beijing, Hangzhou, and Qingdao, and operations in the US, China, Ukraine, and Malaysia.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham



Quick facts: Ideanomics Inc

Price: 3.18 USD

Market: NASDAQ
Market Cap: $1.17 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


PharmaDrug pursuing Orphan Drug Designation with FDA to use DMT in kidney...

PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) CEO Daniel Cohen tells Proactive it has filed an application with the FDA to receive an orphan drug designation for the use of DMT in preventing kidney injuries in patients undergoing kidney transplants. Cohen says the group aims to unlock the potential...

1 hour, 48 minutes ago

2 min read